RARE · Forms 3, 4, 5
Insider trades at Ultragenyx Pharmaceutical Inc.
3 insiders sold $184K of Ultragenyx Pharmaceutical Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Ultragenyx Pharmaceutical Inc. (RARE) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | Sell | 1,283 | $13.57 | $17K | Form 4 | |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | Sell | 161 | $13.99 | $2K | Form 4 | |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | Sell | 1,900 | $24.92 | $47K | Form 4 | |
| Howard Horn | Chief Financial Officer | Sell | 4,696 | $24.92 | $117K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.